Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1113/JP271110 | ||||
| Año | 2016 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
High-altitude hypoxia causes intrauterine growth restriction and cardiovascular programming. However, adult humans and animals that have evolved at altitude show certain protection against the effects of chronic hypoxia. Whether the highland fetus shows similar protection against high altitude gestation is unclear. We tested the hypothesis that high-altitude fetal sheep have evolved cardiovascular compensatory mechanisms to withstand chronic hypoxia that are different from lowland sheep. We studied seven high-altitude (HA; 3600m) and eight low-altitude (LA; 520m) pregnant sheep at approximate to 90% gestation. Pregnant ewes and fetuses were instrumented for cardiovascular investigation. A three-period experimental protocol was performed in vivo: 30min of basal, 1h of acute superimposed hypoxia (approximate to 10% O-2) and 30min of recovery. Further, we determined ex vivo fetal cerebral and femoral arterial function. HA pregnancy led to chronic fetal hypoxia, growth restriction and altered cardiovascular function. During acute superimposed hypoxia, LA fetuses redistributed blood flow favouring the brain, heart and adrenals, whereas HA fetuses showed a blunted cardiovascular response. Importantly, HA fetuses have a marked reduction in umbilical blood flow versus LA. Isolated cerebral arteries from HA fetuses showed a higher contractile capacity but a diminished response to catecholamines. In contrast, femoral arteries from HA fetuses showed decreased contractile capacity and increased adrenergic contractility. The blunting of the cardiovascular responses to hypoxia in fetuses raised in the Alto Andino may indicate a change in control strategy triggered by chronic hypoxia, switching towards compensatory mechanisms that are more cost-effective in terms of oxygen uptake.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | HERRERA-VIDELA, EMILIO AUGUSTO | Hombre |
Universidad de Chile - Chile
|
| 2 | ROJAS-CARRASCO, RODRIGO ALEJANDRO | Hombre |
Universidad de Chile - Chile
|
| 3 | Krause, B. | Hombre |
Universidad de Chile - Chile
|
| 4 | Ebensperger, G. | Hombre |
Universidad de Chile - Chile
|
| 5 | REYES-CATALAN, VICTOR ROBERTO | Hombre |
Universidad de Chile - Chile
|
| 6 | Giussani, Dino A. | Hombre |
UNIV CAMBRIDGE - Reino Unido
University of Cambridge - Reino Unido |
| 7 | Parer, J. T. | Hombre |
UNIV CALIF SAN FRANCISCO - Estados Unidos
University of California, San Francisco - Estados Unidos |
| 8 | LLANOS-MANSILLA, JORGE ANIBAL | Hombre |
Universidad de Chile - Chile
|
| Fuente |
|---|
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Biotechnology and Biological Sciences Research Council |
| Wellcome Trust |
| British Heart Foundation |
| National Fund for Scientific and Technological Development (FONDECYT-Chile) |
| Wellcome Trust Collaborative Research Initiative |
| Agradecimiento |
|---|
| This work was supported by National Fund for Scientific and Technological Development (FONDECYT-Chile), Grant nos 1120605, 1130424, 1140647, 1151119; and The Wellcome Trust Collaborative Research Initiative, Grant no. 072256. |
| This work was supported by National Fund for Scientific and Technological Development (FONDECYT‐Chile), Grant nos 1120605, 1130424, 1140647, 1151119; and The Wellcome Trust Collaborative Research Initiative, Grant no. 072256. |